TDF therapy in pregnancy reduces HBV ... - HFI Connect - Hep...

HFI Connect - Hepatitis

960 members1,215 posts

TDF therapy in pregnancy reduces HBV DNA, risk of vertical transmission

kcohen profile image
0 Replies

Viremic mothers treated with tenofovir disoproxil fumarate during pregnancy had decreased hepatitis B virus infection DNA levels in their blood, which reduced the infection’s DNA serum levels in infants at birth and reduced overall mother-to-child transmission, according to study data.

Article: healio.com/hepatology/chron...

Written by
kcohen profile image
kcohen
To view profiles and participate in discussions please or .
Read more about...